Cited by 151Sepsis Diagnosis and TreatmentImmune Response and InflammationInflammation biomarkers and pathways

The DOI matches its Crossref record; 83 of the 88 references it cites were found in a registry or an index.

Clinical detection of LPS and animal models of endotoxemia

Abstract

The interest in the study of endotoxemia in the clinical area has increased recently as a result of a) improved and simplified endotoxin determination e.g. chromogenic-kinetic microplate methods (also an improved blood sampling tool is available), b) incidence of sepsis has increased due to improvement in early (e.g. posttraumatic) survival, c) interest in and good evidence for gut translocation as a source of endotoxemia, d) agents have developed, which can antagonize endotoxins. There is evidence that patients with positive endotoxin test in the ICU have a higher incidence of organ failure. To study the pathophysiological consequences of endotoxemia and possible ways of intervention animal models are necessary. The choice of the experimental setting depends on the aim of the study e.g. whether prolonged observation is necessary in survival studies or whether hemodynamic variables have to be measured or whether therapeutic agents only crossreact with primates. Since LPS levels are quite low in clinical studies, an important factor for selection of a relevant animal might be LPS sensitivity, or the use of additional sensitization techniques e.g. galactosamine. Another important aspect in this context is whether LPS is given as bolus or infused up to several days. In this review the dose, time, and route of LPS administration is also discussed. For screening purposes rodents are usually used, or sometimes rabbits due to their higher LPS sensitivity. Another very sensitive animal model is the sheep, which can be chronically instrumented and as a specialty allows lung lymph drainage and thus studies of LPS effects on pulmonary permeability. Pigs are used for hemodynamic studies and often in therapeutical studies if species-specificity of the drug tested is not important, in cases where a large animal is necessary. Finally the non-human primates offer a number of advantages due to human-like physiology, due to the cross-reactivity of human assay systems and accordingly also cross-reactivity of human therapeutic agents. While the chimpanzee also shares the LPS sensitivity of humans, baboons are insensitive like rodents. Thus each model serves to provide some useful purpose and the selection must be made to meet the requirements of the specific questions to be asked, with special emphasis of the chosen endotoxin model on relevance for the human sepsis state.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0171-2985(11)80348-7

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 88 references

Research works printed but not linked: 18

  1. Meakins, 1986, Multi-organ-failure syndrome, The gastrointestinal tract: the «motor» of MOF. Arch. Surg., 121, 196
  2. Alexander, 1991, Translocation of endotoxin and bacteria from the gut following burn injury, Circ. Shock, 34, 26
  3. Morris, 1989, Decreased mesenteric blood flow independently promotes bacterial translocation in chronically instrumented sheep, Surg. Forum, 40, 88
  4. Aune, 1982, Quantitative determination of endotoxin in plasma by means of a new chromogenic peptide substrate, A methodological study. Acta Chir. Scand., 509, 55
  5. Bahrami, 1991, A kinetic-chromogenic method to determine endotoxin on microplates, Eur. Clin. Lab. News, 10, 8
  6. Steininger, 1990, Immediate graft function after orthotopic liver transplantation clears endotoxin, Transplant. Proc., 22, 180
  7. Berger, 1991, Neue Aspekte zur Pathogenese und Behandlung der Sepsis und des septischen Schocks, Chirurg, 62, 4
  8. Bahrami, 1991, Endotoxin shock related disorders induced by high- vs low-dose lipopolysaccharide (LPS) injection in rats, Eur. Surg. Res., 23, 60
  9. Schneider, 1987, Effectes of vasodilators prostaglandin E1 and methylprednisolone on pulmonary hypertension and right ventricular performance during volume loading in porcine septic shock, A combined invasive and radionuclide study. Circ. Shock, 22, 141
  10. Johnston, 1989, E coli endotoxin produces hyperdynamic hemodynamics in the rat, Circ. Shock, 27, 320
  11. Keil, 1990, Application of pathway-specific enzyme immunoassays to the study of complement activtion by salmonella endotoxin, J. Clin. Immunoassay, 13, 187
  12. Mann, 1988, Prior infusion of endotoxin diminishes the pulmonary response to bolus administration of lipopolysaccharide (LPS), Proc. Burn. Assoc., 20, 1387
  13. Kreimeier, 1986, Endotoxin induzierte Mikrozirkulationstörung beim Schwein — Verhinderung durch spezifische Antikörper, Langenbecks Arch. Chir., 368, 191
  14. Hoffmann, 1991, Attenuation of endotoxin-induced acute lung injury by pentoxifylline and HWA-138, Circ. Shock, 34, 139
  15. Kosanke, 1982, A comparison of the morphologic lesions in the dog and baboon septic shock models, Lab. Anim. Sci., 32, 420
  16. Fletcher, 1981, Thromboxane prostacyclin and hemodynamic events in primate endotoxin, Adv. Shock Res., 5, 143
  17. Redl, 1992, No tolerance induction by multiple application of live E coli in baboons, Circ. Shock, 37, 39
  18. Van Der Poll, 1992, Tumor necrosis factor (TNF) is involved in the release of its own soluble receptors (sTFNR) in experimental endotoxemia, Eur. Cytokine Network, 3, 214

Cited by

Sorted by citations

Metadata

Authors
Redl, H., Bahrami, S., Schlag, G., & Traber, D. L.
Affiliations
  • Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA (AT)
  • Shriners Hospitals for Children - Galveston (US)
Venue
Immunobiology
Publisher
Elsevier BV
Published
1993-04
Volume
187
Issue
3-5
Pages
330-345
ISSN
0171-2985 (ISSN-L)
OpenAlex
W2060345460
Cited by
151
References
88
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 4 · 2015: 4 · 2014: 5 · 2013: 4 · 2012: 3
FWCI
6.42
Type
journal article
Language
en
Open access
closed
Locations
  • Immunobiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
Keywords
endotoxemia, lipopolysaccharide, animal models, sepsis, gut translocation, organ failure, sheep, pigs, non-human primates, baboons, chimpanzees, lung permeability, hemodynamics, endotoxin antagonists, endotoxin detection
MeSH terms
Animals, Disease Models, Animal, Endotoxins, Humans, Lipopolysaccharides, Toxemia, Bacteremia, Gram-Negative Bacterial Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review